Stocks of CVS Health Corp (NYSE:CVS) traded higher last session on Wall Street, up 1.66% to $66.33.
CVS stock price is now 18.91% away from the 50-day moving average and 15.32% away from the 200-day moving average. The market capitalization of the company currently stands at $83.63B.
With the price target enhanced from $55 to $75, Leerink Partners Upgraded its rating from Market Perform to Outperform for CVS Health Corp (NYSE: CVS). , while ‘Edward Jones’ rates the stock as ‘Buy’
In other news, Clark James David, SVP, Cont & Chief Acct Officer sold 7,513 shares of the company’s stock on Mar 05 ’25. The stock was sold for $498,488 at an average price of $66.35. Upon completion of the transaction, the SVP, Cont & Chief Acct Officer now directly owns 8,394 shares in the company, valued at $0.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 05 ’25, Officer Clark James David bought 7,513 shares of the business’s stock. A total of $498,489 was incurred on buying the stock at an average price of $66.35. A total of 0.13% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $43.56 and a high of $80.75. As of last week, the company has a debt-to-equity ratio of 1.10, a current ratio of 0.81, and a quick ratio of 0.60.
The net profit margin was 1.24% and return on equity was 6.07% for CVS. The company reported revenue of $97.71 billion for the quarter, compared to $93.81 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.15 percent.
